Showing results 17 to 23 of 23
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers Journal:Clinical Pharmacology in Drug Development | 2017 | 51 | ||
2021 | 1 | |||
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold Proceeding/Conference:Journal of Hepatology | 2019 | 73 | ||
2020 | 3 | |||
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent Journal:Antiviral Research | 2015 | |||
T1653 mutation in the box α increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C Infection Journal:Clinical Infectious Diseases | 2006 | 58 | ||
2008 | 55 |